Change in FDA's ethical guidelines for clinical trials troubling

In a commentary published in the Jan. 3 issue of The Lancet, medical research expert Jonathan Kimmelman of McGill University, along with colleagues from the University of Western Ontario and University of Indiana call the FDA's move away from the Declaration of Helsinki as an ethical foundation for international clinical trials "troubling."